Brevan Howard Capital Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$352K Sell
3,784
-894
-19% -$79.2K ﹤0.01% 1524
2025
Q4
$376K Sell
4,678
-9,140
-66% -$765K ﹤0.01% 1250
2025
Q3
$1.35M Sell
13,818
-13,169
-49% -$1.06M 0.01% 763
2025
Q2
$1.88M Buy
+26,987
New +$1.54M 0.01% 760
2024
Q4
Sell
-22,131
Closed -$2.32M 1000
2024
Q3
$2.32M Buy
22,131
+15,588
+238% +$1.82M 0.02% 245
2024
Q2
$930K Buy
6,543
+1,881
+40% +$217K 0.01% 400
2024
Q1
$520K Sell
4,662
-920
-16% -$110K ﹤0.01% 451
2023
Q4
$724K Buy
+5,582
New +$769K 0.01% 349

Other funds holding ACLS

Brevan Howard Capital Management's ACLS Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Axcelis (ACLS) stake by 19% in Q1 2026, selling an estimated $79.2K and leaving 3,784 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

Brevan Howard Capital Management first reported a position in ACLS in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.32M in Q3 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Brevan Howard Capital Management held 3,784 shares of Axcelis worth $352K as of Q1 2026.
  • Brevan Howard Capital Management sold 894 Axcelis shares in Q1 2026, an estimated $79.2K.
  • Axcelis made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1524 holding.
  • Brevan Howard Capital Management first reported a position in Axcelis in Q4 2023 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Axcelis position peaked at $2.32M in Q3 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.